Navigation Links
Cambrex Reports Second Quarter of 2011 Results
Date:8/2/2011

m Continuing Operations

$

4,7577.0%$

3,6666.4%Income  from Discontinued Operations, Net of Tax-1,105Net Income

$

4,7577.0%$

4,7718.3%Basic Earnings per Share of Common Stock:   Income from Continuing Operations

$

0.16$

0.12   Income from Discontinued Operations, Net of Tax

$

-$

0.04   Net Income

$

0.16$

0.16Diluted Earnings per Share of Common Stock:   Income from Continuing Operations

$

0.16$

0.12   Income from Discontinued Operations, Net of Tax

$

-$

0.04   Net Income

$

0.16$

0.16Weighted Average Shares OutstandingBasic29,41929,333Diluted29,49329,404CAMBREX CORPORATIONStatements of Profit and LossFor the Six Months Ended June 30, 2011 and 2010(in thousands)20112010% of% ofAmountSalesAmountSalesGross Sales

$

129,138$

113,558Commissions, Allowances and Rebates814712Net Sales128,324112,846Other6431,464Net Revenues128,967114,310Cost of Goods Sold92,45571.6%81,88472.1%Gross Profit36,51228.3%32,42628.6%Operating ExpensesSelling, General and Administrative Expenses18,27914.1%16,98015.0%Research and Development Expenses5,6324.4%4,8264.2%Total Operating Expenses23,91118.5%21,80619.2%Operating Profit12,6019.8%10,6209.4%Other Expenses/(Income):Interest Expense, net1,1782,369Other (Income)/Expenses, net(285)17Equity in Losses of Partially-Owned Affiliate667-Income Before Income Taxes11,0418.5%8,2347.3%Provision for Income Taxes3,4292,885Income from Continuing Operations

$

7,6125.9%$

5,3494.7%(Loss)/Income  from Discontinued Operations, Net of Tax(146)1,105Net Income

$

7,4665.8%$

6,4545.7%Basic Earnings/(Loss) per Share of Common Stock:   Income from Continuing Operations

$.26$.18   (Loss)/Income from Discontinued Operations, Net of Tax

$

  (0.01)$.04   Net Income

<
'/>"/>
SOURCE Cambrex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Cambrex Reports Third Quarter 2010 Results
2. Cambrex Reports Fourth Quarter and Full Year 2009 Results
3. Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Nominated for 2009 Innovations Award
4. Cambrex Reports First Quarter 2009 Results
5. Cambrex Receives Notice Regarding NYSE Listing
6. Cambrex Reports Third Quarter 2008 Results
7. Jennerex Reports Positive Mechanistic Proof-of-Concept Clinical Trial Results Using JX-594 to Treat Metastatic Melanoma
8. Gen-Probe Reports Financial Results for the Second Quarter of 2011
9. Neurocrine Biosciences Reports Second Quarter 2011 Results
10. United Therapeutics Corporation Reports Second Quarter 2011 Financial Results
11. Sangamo BioSciences Reports Second Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... Baltimore, MD (PRWEB) November 24, 2014 ... recruiting underrepresented patient populations into clinical trials at ... Maryland. , “Continental was created with the ... trials play a fundamental role in medical advances," ... the Tuskegee syphilis experiment to the immortal cell ...
(Date:11/23/2014)... 23, 2014 Apiscent Labs, a ... fine chemical ingredients to the global pharmaceutical and ... its new website, Apiscent.com. , The Apiscent.com homepage ... clean design, easy navigation, rotating images and content ... stand out. , The company’s work ...
(Date:11/22/2014)... RURO, Inc., a leading LIMS, RFID ... version 5.1.4. , RURO’s deployment teams have been ... in RURO’s 8 year history. Many deployments have ... version 5.1.4 is the perfect example – the ... , Limfinity® 5.1.4 release highlights – more than ...
(Date:11/22/2014)... --   , ... KLOX    Mariano Rodriguez ... bestellt    KLOX ist bestens vorbereitet, ... Behandlungssystems zur Wundheilung zu beginnen    , ... erfreut, die folgenden personellen Veränderungen anzukündigen: ...
Breaking Biology Technology:At Continental Clinical Solutions, CEO Saleh Stevens Focuses on Diversity in Clinical Trial Recruitment at Maryland Site 2At Continental Clinical Solutions, CEO Saleh Stevens Focuses on Diversity in Clinical Trial Recruitment at Maryland Site 3RURO Announces Limfinity® version 5.1.4 2KLOX Technologies meldet Neubesetzung von Führungspositionen 2KLOX Technologies meldet Neubesetzung von Führungspositionen 3KLOX Technologies meldet Neubesetzung von Führungspositionen 4KLOX Technologies meldet Neubesetzung von Führungspositionen 5
... 21, 2012 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group (NYSE: ... the development, manufacturing, and marketing of branded generic and ... report its unaudited financial results for the fourth quarter ... March 7, 2012, before the market opens in the ...
... University have developed a new method for chemically ... step toward the creation of faster, thinner, flexible ... attributes, graphene is a one-atom thick, honeycomb-shaped lattice ... Among graphene,s many possible applications is electronics: Many ...
... announced that it has held an End-of-Phase 2 meeting with ... clinical studies completed for XaraColl ® and to discuss ... Phase 3. XaraColl ® is being developed for postoperative ... in patients undergoing hernia repair. FDA agreed to the Phase ...
Cached Biology Technology:Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2011 Financial Results on Wednesday, March 7, 2012 2A step toward better electronics 2Innocoll Announces Successful End-of-Phase 2 Meeting with FDA for XaraColl® and Agreement of the Phase 3 Program 2
(Date:11/21/2014)... C-Labs LLC, a leading provider of remote ... today announced the appointment of John Traynor ... strategic advisor to the firm, Mr. Traynor will now ... based out of the C-Labs office in ... Muench , Chief Executive Officer. Photo - ...
(Date:11/18/2014)... -- The Secure Identity & Biometrics Association (SIBA) and ... formation of The Airport Entry and Exit Working ... Biometric Entry and Exit Solutions Framework for Airports ... BORDERPOL, the international non-profit organization that works directly ... border security, traveler and migration systems. ...
(Date:11/18/2014)... , Nov. 17, 2014 The Parenteral Drug Association ... regulatory agencies will speak and at least seven more will ... at the Omni Shoreham Hotel in Washington D.C. ... again to have significant support from the regulatory agencies in ... Europe in our effort to help advance the ...
Breaking Biology News(10 mins):C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2
... on understanding how stem cells, cells capable of transforming into ... being programmed down a defined path to contribute to the ... kidney. Research from the University of North Carolina at Chapel ... epigenetic signals may function together to determine the ultimate fate ...
... or nerve cells, embryonic stem cells are by definition equipped ... meaning that as an organism develops, stem cells must be ... expression programs used to turn them into blood, brain, or ... Investigator Ali Shilatifard, Ph.D., report in the December 27, 2012 ...
... only happier, but also find greater acceptance in their peer ... open access journal PLOS ONE by Kristin Layous ... authors randomly assigned over 400 students aged 9-12 to two ... kept track of pleasant places they visited each week. Examples ...
Cached Biology News:UNC research uncovers new insight into cell development and cancer 2Stowers study hints that stem cells prepare for maturity much earlier than anticipated 2Stowers study hints that stem cells prepare for maturity much earlier than anticipated 3
Packaging: package with 500 l Patent/trademark/license (electronic): (r) Registered trademark of Molecular Probes...
... 100-120 V, is used for protein separation ... The system includes both the mini (18 ... chassis, harvesting apparatus, cooling finger, electrode chambers, ... ml syringe, colored protein sample, 2 vent ...
...
... NH2 is primarily used for the preparation ... proteins for tracing. NH2-Reactive B-Phycoerythrin, a component ... and can easily make a covalent bond ... proteins without any activation process. Filtration Tube ...
Biology Products: